Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) Profit Margin

Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) (ELAT) currently reports a profit margin of -3.96% as of June 2026. That compares with 41.36% in the prior-year period — down 109.6% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s profit margin history and peer comparisons.

Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s profit margin decreased from 41.36% to -3.96% — a 109.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s profit margin of -3.96% is lower than the Healthcare sector average of 13.76%. That is roughly 128.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s current -3.96% should be judged against Healthcare norms (sector average: 13.76%) and against ELAT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -3.96%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note), and consider following ELAT for alerts when major investors trade the stock.